CD8A and neoplasm: In this model, G47Δ-mIL12 monotherapy significantly inhibited TNBC tumor growth and prevented metastasis, both at early and late-stages of tumor development, and was associated with increased DC maturation and T cell activation, enhanced infiltration of CD8+ T cells and reduced infiltration of MDSCs into treated and distant tumors.